Reckitt Benckiser to acquire Adams for $2.3 billion
UK-based cleaning products manufacturer Reckitt Benckiser announced Monday that it has agreed to buy US OTC drug maker Adams Respiratory Therapeutics for $2.3 billion.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.